Catalyst Wire Dossier Catalyst Wire Dossier

MEV-90 0.5% ropivacaine

ropivacaine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEV-90 0.5% ropivacaine, covering 2019-01-31 to 2019-01-31. Get the full timeline:

Most recent: Clinical Trial Update: MEV 90 of 0.5% Ropivacaine In Infraclavicular Blocks [NA]

See pricing